Hexagon Capital Partners LLC Has $658,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Hexagon Capital Partners LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 15.5% in the 4th quarter, Holdings Channel reports. The institutional investor owned 1,251 shares of the healthcare conglomerate’s stock after acquiring an additional 168 shares during the period. Hexagon Capital Partners LLC’s holdings in UnitedHealth Group were worth $658,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in UNH. Wellington Management Group LLP boosted its position in shares of UnitedHealth Group by 2.1% in the third quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock valued at $12,715,790,000 after acquiring an additional 527,526 shares during the period. Northern Trust Corp boosted its position in shares of UnitedHealth Group by 3.6% in the third quarter. Northern Trust Corp now owns 9,787,768 shares of the healthcare conglomerate’s stock valued at $4,934,895,000 after acquiring an additional 341,749 shares during the period. Bank of New York Mellon Corp lifted its position in UnitedHealth Group by 2.2% in the third quarter. Bank of New York Mellon Corp now owns 8,242,282 shares of the healthcare conglomerate’s stock worth $4,155,676,000 after purchasing an additional 180,331 shares during the period. Charles Schwab Investment Management Inc. lifted its position in UnitedHealth Group by 0.5% in the third quarter. Charles Schwab Investment Management Inc. now owns 5,843,207 shares of the healthcare conglomerate’s stock worth $2,937,976,000 after purchasing an additional 27,127 shares during the period. Finally, Sanders Capital LLC lifted its position in UnitedHealth Group by 6.5% in the third quarter. Sanders Capital LLC now owns 5,757,410 shares of the healthcare conglomerate’s stock worth $2,902,829,000 after purchasing an additional 352,710 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the SEC, which is available through this link. In other news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages recently commented on UNH. Morgan Stanley reduced their target price on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research report on Friday, April 5th. Wells Fargo & Company dropped their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective for the company in a research note on Thursday, April 4th. Barclays increased their price objective on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Finally, Stephens restated an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a research note on Thursday, February 8th. Four investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $570.05.

UnitedHealth Group Stock Down 1.1 %

Shares of NYSE:UNH traded down $5.33 during trading on Tuesday, hitting $483.70. 3,366,904 shares of the company were exchanged, compared to its average volume of 4,466,545. The stock has a market cap of $445.04 billion, a price-to-earnings ratio of 29.57, a P/E/G ratio of 1.43 and a beta of 0.54. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The firm has a fifty day moving average price of $484.44 and a two-hundred day moving average price of $513.42. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s revenue was up 8.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $6.26 EPS. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s payout ratio is 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.